The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...

Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...